Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
Generic inhalers can cost as little as $30 ... That includes the company's popular Trelegy Ellipta and other Ellipta inhaler ...
pharmaphorum4 年
GSK steals march on AZ as FDA approves Trelegy in asthma
The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults, adding to its existing use in chronic obstructive pulmonary disease (COPD), stealing a march on rivals ...
Medical News Today1 个月
Trelegy Ellipta for COPD
Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is a brand-name inhaler that’s prescribed for COPD. This article covers topics such as side effects, dosage ...
pharmaphorum7 年
GSK looks to expand reach of key COPD drug Trelegy
Trelegy is a key drug for GSK, and analysts predict peak sales in excess of $1billion. The company needs new revenues in respiratory diseases, as its ageing blockbuster inhaler Advair will face ...